VTRS FY 2020 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$17B

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$11.9B+3.9% YoY

Gross Profit

$3.8B31.8% margin

Operating Income

-$211M-1.8% margin

Net Income

-$670M-5.6% margin

EPS (Diluted)

$-1.11

Cash Flow

Operating Cash Flow

$1.2B

Free Cash Flow

$551M

Stock-Based Comp.

$79M

Balance Sheet

Total Assets

$61.6B

Total Liabilities

$38.6B

Stockholders' Equity

$23.0B

Cash & Equivalents

$844M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11.9B	$11.5B	+3.9%
Gross Profit	$3.8B	$3.9B	-2.6%
Operating Income	-$211M	$716M	-129.5%
Net Income	-$670M	$17M	-4087.5%